FDA experts vote against the efficacy of Biogen’s ALS treatment for a rare and aggressive type…
The Food and Drug Administration's independent panel of experts decided on Wednesday against Biogen's ALS treatment efficacy.
ALS medication is under consideration for a rare and aggressive type of illness. Tofersen is a medication that…